""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	11	0.36575	0.21424	1	-0.36575	0.78576	0.8977	-13.012	0.79912	0.99992	8	-12.007	0.81555	0.95254	3	-5.3096	0.51432	0.99997
"2"	"AGE-RAGE signaling pathway in diabetic complications"	39	-0.93434	0.99367	1	0.93434	0.0063303	0.062282	-19.025	0.49355	0.91788	10	-7.7244	0.26411	0.68162	29	-17.527	0.6419	0.99997
"3"	"AMPK signaling pathway"	56	0.20481	0.31734	1	-0.20481	0.68266	0.86431	-22.137	0.39727	0.81719	27	-12.919	0.16529	0.60456	29	-18.296	0.72347	0.99997
"4"	"Acute myeloid leukemia"	28	-0.4793	0.89348	1	0.4793	0.10652	0.36099	-20.332	0.88382	0.99992	8	-6.0593	0.21353	0.65611	20	-20.225	0.96864	0.99997
"5"	"Adherens junction"	32	0.082155	0.44153	1	-0.082155	0.55847	0.79225	-14.932	0.23965	0.68172	19	-11.929	0.30808	0.7014	13	-9.0054	0.28536	0.86764
"6"	"Adipocytokine signaling pathway"	31	0.35093	0.203	1	-0.35093	0.797	0.90617	-19.935	0.78214	0.99992	17	-11.798	0.38237	0.77249	14	-16.664	0.94412	0.99997
"7"	"Adrenergic signaling in cardiomyocytes"	57	-0.58471	0.94208	1	0.58471	0.057915	0.24149	-18.685	0.08371	0.4118	28	-14.683	0.28871	0.69099	29	-11.769	0.087617	0.72829
"8"	"African trypanosomiasis"	14	0.35441	0.1933	1	-0.35441	0.8067	0.91127	-7.8305	0.14136	0.54575	8	-5.1928	0.14897	0.60456	6	-5.9652	0.33614	0.919
"9"	"Alanine, aspartate and glutamate metabolism"	16	-0.74217	0.97314	1	0.74217	0.026865	0.16388	-8.4028	0.13179	0.54575	6	-8.7892	0.61978	0.88043	10	-3.8207	0.043304	0.64522
"10"	"Alcoholism"	29	-0.634	0.95494	1	0.634	0.045061	0.22167	-13.999	0.22782	0.68172	11	-13.813	0.84094	0.9597	18	-6.97	0.046089	0.65402
"11"	"Aldosterone synthesis and secretion"	24	0.097152	0.41048	1	-0.097152	0.58952	0.82478	-13.241	0.28009	0.72397	15	-11.309	0.42428	0.7968	9	-7.0223	0.25501	0.85438
"12"	"Aldosterone-regulated sodium reabsorption"	16	-0.035264	0.56389	1	0.035264	0.43611	0.70753	-11.736	0.42809	0.84553	7	-4.5636	0.13125	0.60456	9	-11.623	0.74887	0.99997
"13"	"Allograft rejection"	4	-0.17092	0.68037	1	0.17092	0.31963	0.63295	-9.3163	0.82222	0.99992	1	-8.2095	0.9244	0.96981	3	-6.0177	0.59718	0.99997
"14"	"Alzheimer disease"	113	3.1009	5.5511e-16	2.8218e-14	-3.1009	1	1	-12.467	1.9064e-09	1.9381e-07	91	-10.064	2.9881e-09	2.9782e-07	22	-7.7868	0.037816	0.64522
"15"	"Amino sugar and nucleotide sugar metabolism"	27	-0.9614	0.99287	1	0.9614	0.0071282	0.065882	-9.2716	0.026373	0.3218	9	-7.2196	0.26542	0.68162	18	-6.2503	0.029347	0.64522
"16"	"Aminoacyl-tRNA biosynthesis"	21	0.84881	0.017001	0.34569	-0.84881	0.983	1	-9.1146	0.071005	0.39015	16	-9.6033	0.19041	0.61882	5	-1.5004	0.062702	0.67806
"17"	"Amoebiasis"	42	-1.5091	0.99997	1	1.5091	3.4323e-05	0.0014955	-17.064	0.19347	0.63488	13	-10.055	0.35128	0.73545	29	-13.803	0.22717	0.85438
"18"	"Amphetamine addiction"	20	-0.32272	0.82839	1	0.32272	0.17161	0.47505	-8.3485	0.069493	0.39015	9	-7.4869	0.29119	0.69099	11	-4.4851	0.052864	0.65639
"19"	"Amyotrophic lateral sclerosis (ALS)"	21	-0.20307	0.72122	1	0.20307	0.27878	0.60176	-7.6282	0.028147	0.3218	7	-1.138	0.017298	0.27222	14	-8.5379	0.22411	0.85438
"20"	"Antigen processing and presentation"	24	0.043287	0.46537	1	-0.043287	0.53463	0.76916	-13.725	0.32788	0.74121	12	-8.4777	0.24658	0.677	12	-10.933	0.55057	0.99997
"21"	"Apelin signaling pathway"	54	-0.32634	0.85308	1	0.32634	0.14692	0.43317	-21.964	0.39943	0.81719	26	-15.978	0.51929	0.81336	28	-15.106	0.34735	0.94101
"22"	"Apoptosis"	49	0.027714	0.51285	1	-0.027714	0.48715	0.7392	-25.012	0.83853	0.99992	20	-7.2966	0.02426	0.36132	29	-26.453	0.99877	0.99997
"23"	"Arachidonic acid metabolism"	15	-0.15305	0.68338	1	0.15305	0.31662	0.63295	-10.234	0.31458	0.74121	6	-7.3921	0.46391	0.79788	9	-7.1763	0.2695	0.85438
"24"	"Arginine and proline metabolism"	27	0.15852	0.3734	1	-0.15852	0.6266	0.83861	-8.8607	0.019905	0.26395	14	-7.7979	0.12764	0.60456	13	-4.6773	0.03323	0.64522
"25"	"Arginine biosynthesis"	11	0.0058918	0.53249	1	-0.0058918	0.46751	0.73137	-7.6025	0.23197	0.68172	7	-8.3252	0.48776	0.81336	4	-1.5942	0.092412	0.72829
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	36	-1.7163	1	1	1.7163	2.1414e-06	0.00013062	-13.259	0.064545	0.37144	13	-8.7044	0.22211	0.65611	23	-10.045	0.099838	0.74459
"27"	"Ascorbate and aldarate metabolism"	6	0.17495	0.33331	1	-0.17495	0.66669	0.85091	-4.113	0.17348	0.59369	3	-0.67603	0.079523	0.56613	3	-5.1407	0.49432	0.99997
"28"	"Asthma"	2	-0.14222	0.66687	1	0.14222	0.33313	0.63503	-6.5099	0.70831	0.99992	0				2	-6.5099	0.73534	0.99997
"29"	"Autoimmune thyroid disease"	4	-0.17092	0.68037	1	0.17092	0.31963	0.63295	-9.3163	0.82222	0.99992	1	-8.2095	0.9244	0.96981	3	-6.0177	0.59718	0.99997
"30"	"Autophagy"	56	-0.86218	0.98732	1	0.86218	0.012685	0.096723	-26.887	0.86158	0.99992	21	-16.076	0.6983	0.91376	35	-21.557	0.85203	0.99997
"31"	"Axon guidance"	55	-0.5658	0.93982	1	0.5658	0.060175	0.24149	-25.082	0.7623	0.99992	23	-16.881	0.70715	0.91376	32	-18.571	0.64708	0.99997
"32"	"B cell receptor signaling pathway"	27	-0.86248	0.9863	1	0.86248	0.0137	0.097897	-19.796	0.86514	0.99992	8	-11.061	0.73544	0.92332	19	-16.421	0.80915	0.99997
"33"	"Bacterial invasion of epithelial cells"	42	-0.12932	0.6788	1	0.12932	0.3212	0.63295	-18.802	0.35295	0.75345	17	-14.108	0.64123	0.88763	25	-12.736	0.2468	0.85438
"34"	"Basal cell carcinoma"	4	0.3047	0.23355	1	-0.3047	0.76645	0.89674	-12.367	0.96455	0.99992	2	-5.8801	0.6611	0.89617	2	-11.61	0.98234	0.99997
"35"	"Basal transcription factors"	4	0.49975	0.11168	1	-0.49975	0.88832	0.954	-8.5126	0.75536	0.99992	2	-0.42853	0.11965	0.60456	2	-11.61	0.98234	0.99997
"36"	"Base excision repair"	8	-0.22893	0.73482	1	0.22893	0.26518	0.58187	-16.373	0.99041	0.99992	3	-11.296	0.94983	0.98955	5	-11.961	0.9344	0.99997
"37"	"Bile secretion"	15	0.1398	0.38079	1	-0.1398	0.61921	0.83737	-10.689	0.36328	0.76945	9	-7.4816	0.29067	0.69099	6	-7.7379	0.53856	0.99997
"38"	"Biosynthesis of unsaturated fatty acids"	11	-0.1139	0.64514	1	0.1139	0.35486	0.64809	-8.6979	0.33933	0.74826	5	-4.6836	0.24673	0.677	6	-7.5015	0.51097	0.99997
"39"	"Bladder cancer"	12	-0.55476	0.94127	1	0.55476	0.058732	0.24149	-11.348	0.60259	0.99992	4	-9.0944	0.79546	0.95254	8	-7.468	0.39297	0.97855
"40"	"Breast cancer"	22	-0.14616	0.69228	1	0.14616	0.30772	0.63295	-20.013	0.94197	0.99992	8	-8.0686	0.41203	0.78973	14	-18.989	0.98816	0.99997
"41"	"Butanoate metabolism"	16	0.18191	0.35109	1	-0.18191	0.64891	0.8458	-10.822	0.3307	0.74164	9	-5.2056	0.11401	0.60456	7	-10.459	0.75857	0.99997
"42"	"C-type lectin receptor signaling pathway"	33	-1.2311	0.99964	1	1.2311	0.00036232	0.0069066	-19.705	0.73006	0.99992	8	-11.062	0.73557	0.92332	25	-16.382	0.63601	0.99997
"43"	"Calcium signaling pathway"	51	-0.53057	0.92995	1	0.53057	0.070052	0.26707	-15.615	0.034891	0.3218	23	-10.308	0.095873	0.60456	28	-11.731	0.078378	0.72705
"44"	"Carbohydrate digestion and absorption"	12	0.30569	0.22729	1	-0.30569	0.77271	0.89762	-10.142	0.46113	0.88262	8	-5.4909	0.16953	0.60456	4	-9.8005	0.84954	0.99997
"45"	"Cardiac muscle contraction"	41	1.4474	0.00012577	0.0047951	-1.4474	0.99987	1	-9.0532	0.00081851	0.024965	33	-7.0427	0.0010209	0.033918	8	-6.1914	0.25619	0.85438
"46"	"Cell adhesion molecules (CAMs)"	24	-0.0072278	0.51748	1	0.0072278	0.48252	0.7392	-24.548	0.99547	0.99992	10	-16.963	0.978	0.99126	14	-17.804	0.97256	0.99997
"47"	"Cell cycle"	32	0.076841	0.44688	1	-0.076841	0.55312	0.79203	-27.153	0.99743	0.99992	17	-19.598	0.97335	0.99126	15	-18.796	0.98191	0.99997
"48"	"Cellular senescence"	49	-0.062038	0.60344	1	0.062038	0.39656	0.66456	-18.182	0.15466	0.56805	25	-11.598	0.10754	0.60456	24	-14.143	0.42305	0.97855
"49"	"Central carbon metabolism in cancer"	33	-0.30303	0.81685	1	0.30303	0.18315	0.48563	-15.602	0.2942	0.73551	12	-7.3894	0.15745	0.60456	21	-13.972	0.5204	0.99997
"50"	"Chagas disease (American trypanosomiasis)"	33	-0.92461	0.9948	1	0.92461	0.0052019	0.054571	-21.607	0.8745	0.99992	11	-12.871	0.76407	0.9363	22	-17.362	0.82707	0.99997
"51"	"Chemical carcinogenesis"	21	-0.088305	0.61454	1	0.088305	0.38546	0.65473	-7.9419	0.0347	0.3218	9	-4.4193	0.076155	0.5645	12	-6.6788	0.12922	0.80223
"52"	"Chemokine signaling pathway"	50	-0.55243	0.94332	1	0.55243	0.056676	0.24149	-27.529	0.95235	0.99992	19	-17.942	0.89039	0.96981	31	-20.916	0.8829	0.99997
"53"	"Cholesterol metabolism"	21	-0.011754	0.53753	1	0.011754	0.46247	0.73085	-10.342	0.13467	0.54575	9	-6.0947	0.17106	0.60456	12	-8.4034	0.2675	0.85438
"54"	"Choline metabolism in cancer"	35	-0.56989	0.94043	1	0.56989	0.05957	0.24149	-20.079	0.68221	0.99992	14	-10.05	0.31215	0.7014	21	-17.717	0.86921	0.99997
"55"	"Cholinergic synapse"	30	-0.23972	0.76277	1	0.23972	0.23723	0.53997	-17.138	0.55527	0.95848	15	-11.712	0.47145	0.80094	15	-12.524	0.60552	0.99997
"56"	"Chronic myeloid leukemia"	30	-0.55594	0.94047	1	0.55594	0.059527	0.24149	-22.424	0.9555	0.99992	9	-10.628	0.63788	0.88763	21	-19.844	0.95831	0.99997
"57"	"Circadian entrainment"	29	-0.40293	0.86028	1	0.40293	0.13972	0.41779	-14.123	0.23908	0.68172	13	-11.572	0.51924	0.81336	16	-8.5836	0.15925	0.84743
"58"	"Circadian rhythm"	9	0.84159	0.014649	0.31914	-0.84159	0.98535	1	-7.0182	0.24587	0.68172	9	-7.0182	0.2468	0.677	0			
"59"	"Citrate cycle (TCA cycle)"	29	1.249	0.00047992	0.014638	-1.249	0.99952	1	-7.1738	0.0029005	0.06805	24	-6.7523	0.0087469	0.16346	5	-2.4831	0.10625	0.7518
"60"	"Cocaine addiction"	10	-0.24633	0.7552	1	0.24633	0.2448	0.54498	-7.3104	0.23743	0.68172	2	-0.88529	0.14839	0.60456	8	-7.7306	0.4236	0.97855
"61"	"Collecting duct acid secretion"	11	-1.096	0.99707	1	1.096	0.0029284	0.035662	-3.9232	0.035872	0.3218	3	-5.7069	0.51489	0.81336	8	-1.1056	0.014515	0.64522
"62"	"Colorectal cancer"	31	-0.2089	0.72728	1	0.2089	0.27272	0.59415	-20.151	0.80054	0.99992	12	-9.1303	0.3108	0.7014	19	-18.484	0.92816	0.99997
"63"	"Complement and coagulation cascades"	38	-0.14432	0.70859	1	0.14432	0.29141	0.61069	-20.284	0.65351	0.99992	17	-13.115	0.53091	0.8225	21	-15.485	0.68588	0.99997
"64"	"Cortisol synthesis and secretion"	9	-0.29887	0.80244	1	0.29887	0.19756	0.48563	-7.1274	0.25637	0.69664	4	-5.5957	0.43276	0.7968	5	-4.5575	0.25994	0.85438
"65"	"Cushing syndrome"	33	-0.12876	0.66944	1	0.12876	0.33056	0.63503	-18.838	0.64399	0.99992	17	-14.258	0.65713	0.89617	16	-12.358	0.54177	0.99997
"66"	"Cysteine and methionine metabolism"	29	0.11128	0.38861	1	-0.11128	0.61139	0.83621	-8.3006	0.0076224	0.16606	13	-2.5172	0.0058651	0.12783	16	-8.906	0.18316	0.85438
"67"	"Cytokine-cytokine receptor interaction"	3	0.081169	0.40876	1	-0.081169	0.59124	0.82478	-10.182	0.92204	0.99992	3	-10.182	0.90713	0.96981	0			
"68"	"Cytosolic DNA-sensing pathway"	11	0.17285	0.3731	1	-0.17285	0.6269	0.83861	-20.749	0.99898	0.99992	4	-5.6755	0.44171	0.7968	7	-21.72	0.99997	0.99997
"69"	"D-Glutamine and D-glutamate metabolism"	3	0.23776	0.2676	1	-0.23776	0.7324	0.89285	-5.472	0.52528	0.94183	2	-5.9158	0.66491	0.89617	1	-1.1115	0.29115	0.86764
"70"	"DNA replication"	9	-0.016041	0.53942	1	0.016041	0.46058	0.73085	-12.493	0.83288	0.99992	4	-5.7762	0.45303	0.7968	5	-11.595	0.91968	0.99997
"71"	"Dilated cardiomyopathy (DCM)"	45	-1.8265	1	1	1.8265	1.5498e-06	0.00011817	-12.936	0.01336	0.21446	18	-8.8789	0.12316	0.60456	27	-9.4512	0.031921	0.64522
"72"	"Dopaminergic synapse"	46	-0.89732	0.99097	1	0.89732	0.0090302	0.078692	-17.415	0.15645	0.56805	19	-15.861	0.73554	0.92332	27	-9.4255	0.031389	0.64522
"73"	"Drug metabolism"	38	-0.54945	0.94421	1	0.54945	0.055791	0.24149	-15.052	0.1264	0.54575	16	-10.672	0.28381	0.69099	22	-10.681	0.16983	0.85438
"74"	"ECM-receptor interaction"	38	-2.2621	1	1	2.2621	1.0156e-09	3.0975e-07	-13.704	0.061801	0.36249	8	-7.5477	0.35547	0.73545	30	-11.526	0.060452	0.67806
"75"	"Endocrine and other factor-regulated calcium reabsorption"	21	0.33272	0.21414	1	-0.33272	0.78586	0.8977	-13.757	0.46301	0.88262	15	-13.003	0.62208	0.88043	6	-5.1778	0.25658	0.85438
"76"	"Endocytosis"	125	-0.041749	0.60634	1	0.041749	0.39366	0.66335	-32.933	0.32696	0.74121	63	-25.169	0.51816	0.81336	62	-21.391	0.23783	0.85438
"77"	"Endometrial cancer"	20	-0.28938	0.80458	1	0.28938	0.19542	0.48563	-15.492	0.68149	0.99992	6	-5.4074	0.25705	0.68016	14	-14.976	0.86487	0.99997
"78"	"Epithelial cell signaling in Helicobacter pylori infection"	30	-1.3015	0.99981	1	1.3015	0.00019445	0.004826	-18.379	0.69342	0.99992	8	-15.604	0.97273	0.99126	22	-12.052	0.28588	0.86764
"79"	"Epstein-Barr virus infection"	74	-0.3146	0.82711	1	0.3146	0.17289	0.47505	-36.204	0.99812	0.99992	30	-23.368	0.97581	0.99126	44	-27.655	0.98855	0.99997
"80"	"ErbB signaling pathway"	39	-0.42765	0.87855	1	0.42765	0.12145	0.39405	-22.335	0.82405	0.99992	15	-10.03	0.28441	0.69099	24	-20.542	0.95453	0.99997
"81"	"Estrogen signaling pathway"	34	-0.68256	0.96405	1	0.68256	0.035953	0.19582	-16.371	0.32808	0.74121	12	-9.3944	0.33871	0.72339	22	-13.413	0.42905	0.98351
"82"	"Ether lipid metabolism"	10	-0.37426	0.84687	1	0.37426	0.15313	0.44061	-13.797	0.87322	0.99992	3	-5.8365	0.52972	0.8225	7	-12.67	0.91121	0.99997
"83"	"Fanconi anemia pathway"	5	0.10433	0.39864	1	-0.10433	0.60136	0.8262	-8.646	0.70985	0.99992	3	-5.9425	0.54182	0.82655	2	-6.3924	0.72408	0.99997
"84"	"Fat digestion and absorption"	9	0.0043386	0.51788	1	-0.0043386	0.48212	0.7392	-7.9481	0.34208	0.74826	5	-2.7765	0.11288	0.60456	4	-8.8179	0.77392	0.99997
"85"	"Fatty acid biosynthesis"	7	0.36547	0.15978	1	-0.36547	0.84022	0.9285	-5.267	0.19745	0.63488	4	-4.9391	0.36091	0.73912	3	-2.3423	0.19911	0.85438
"86"	"Fatty acid degradation"	32	0.62986	0.06138	1	-0.62986	0.93862	0.99058	-11.989	0.0604	0.36122	21	-8.1701	0.042586	0.49187	11	-9.1607	0.39674	0.97855
"87"	"Fatty acid elongation"	15	-0.19032	0.71786	1	0.19032	0.28214	0.60176	-7.0524	0.078691	0.40719	8	-5.3303	0.15824	0.60456	7	-4.6253	0.15759	0.84743
"88"	"Fc epsilon RI signaling pathway"	27	-0.59348	0.93817	1	0.59348	0.061834	0.24179	-16.918	0.60731	0.99992	9	-10.082	0.57757	0.85492	18	-13.592	0.58535	0.99997
"89"	"Fc gamma R-mediated phagocytosis"	41	0.18351	0.34612	1	-0.18351	0.65388	0.84865	-17.87	0.29198	0.73551	20	-9.1661	0.077407	0.5645	21	-16.025	0.73841	0.99997
"90"	"Ferroptosis"	21	0.10234	0.42099	1	-0.10234	0.57901	0.81758	-10.269	0.13004	0.54575	12	-8.566	0.25483	0.68016	9	-5.7957	0.15544	0.84743
"91"	"Fluid shear stress and atherosclerosis"	58	-0.56352	0.93827	1	0.56352	0.061726	0.24179	-25.4	0.69263	0.99992	24	-16.479	0.64911	0.89042	34	-19.329	0.6954	0.99997
"92"	"Focal adhesion"	101	-1.3195	0.99981	1	1.3195	0.00019412	0.004826	-25.127	0.03268	0.3218	36	-13.288	0.051422	0.53018	65	-21.432	0.18364	0.85438
"93"	"Folate biosynthesis"	11	-0.32086	0.80908	1	0.32086	0.19092	0.48563	-4.7279	0.058548	0.36122	5	-5.3253	0.30586	0.7014	6	-1.5402	0.04266	0.64522
"94"	"FoxO signaling pathway"	42	-0.093487	0.64543	1	0.093487	0.35457	0.64809	-19.921	0.4748	0.89947	17	-8.6801	0.11674	0.60456	25	-18.663	0.83978	0.99997
"95"	"Fructose and mannose metabolism"	21	-0.58647	0.94214	1	0.58647	0.057863	0.24149	-8.8215	0.059952	0.36122	6	-2.3932	0.066066	0.54871	15	-8.9242	0.2173	0.85438
"96"	"GABAergic synapse"	19	-0.63924	0.95175	1	0.63924	0.048246	0.23357	-10.792	0.20377	0.64072	8	-11.951	0.81133	0.95254	11	-3.9911	0.039123	0.64522
"97"	"Galactose metabolism"	15	-0.85241	0.99039	1	0.85241	0.0096082	0.079203	-7.3771	0.093603	0.44363	4	-5.6367	0.43735	0.7968	11	-5.2156	0.079887	0.72705
"98"	"Gap junction"	28	-0.12248	0.63767	1	0.12248	0.36233	0.64974	-14.34	0.27804	0.72397	11	-5.1184	0.057611	0.54279	17	-14.287	0.70684	0.99997
"99"	"Gastric acid secretion"	23	-0.26911	0.79393	1	0.26911	0.20607	0.49488	-8.6546	0.035551	0.3218	11	-7.3658	0.18142	0.60947	12	-4.9295	0.049768	0.65639
"100"	"Gastric cancer"	29	0.059126	0.44253	1	-0.059126	0.55747	0.79225	-23.917	0.98533	0.99992	12	-9.5597	0.35666	0.73545	17	-23.205	0.99929	0.99997
"101"	"Glioma"	25	-0.075654	0.6136	1	0.075654	0.3864	0.65473	-18.174	0.79233	0.99992	10	-8.0324	0.29373	0.69153	15	-16.904	0.93869	0.99997
"102"	"Glucagon signaling pathway"	49	-0.083654	0.62463	1	0.083654	0.37537	0.65421	-20.101	0.32517	0.74121	24	-15.045	0.49042	0.81336	25	-13.401	0.30982	0.87929
"103"	"Glutamatergic synapse"	27	-0.86131	0.9862	1	0.86131	0.013802	0.097897	-12.362	0.14821	0.55807	12	-13.858	0.81473	0.95254	15	-4.1897	0.015353	0.64522
"104"	"Glutathione metabolism"	34	0.034599	0.49239	1	-0.034599	0.50761	0.74714	-10.447	0.015023	0.2291	15	-2.7882	0.0033093	0.089952	19	-11.498	0.29917	0.87305
"105"	"Glycerolipid metabolism"	20	0.36971	0.18003	1	-0.36971	0.81997	0.91274	-9.6782	0.13214	0.54575	11	-6.6216	0.12919	0.60456	9	-7.1069	0.26292	0.85438
"106"	"Glycerophospholipid metabolism"	29	-0.29778	0.78888	1	0.29778	0.21112	0.50271	-20.437	0.87549	0.99992	15	-14.984	0.81534	0.95254	14	-13.904	0.78603	0.99997
"107"	"Glycine, serine and threonine metabolism"	17	-0.0046662	0.53816	1	0.0046662	0.46184	0.73085	-9.414	0.17713	0.59369	8	-5.6026	0.17769	0.60456	9	-7.6561	0.31717	0.89167
"108"	"Glycolysis / Gluconeogenesis"	47	-0.75566	0.97989	1	0.75566	0.020109	0.12624	-10.667	0.0012181	0.031506	18	-6.376	0.031105	0.40437	29	-8.5562	0.010313	0.64522
"109"	"Glycosaminoglycan degradation"	5	0.42942	0.13531	1	-0.42942	0.86469	0.94189	-8.373	0.68197	0.99992	4	-5.2566	0.39521	0.78022	1	-8.2095	0.93611	0.99997
"110"	"Glycosphingolipid biosynthesis"	2	0.48212	0.10462	1	-0.48212	0.89538	0.95486	-1.0812	0.16131	0.57882	2	-1.0812	0.16204	0.60456	0			
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	4	-0.12593	0.63894	1	0.12593	0.36106	0.64974	-9.3928	0.82792	0.99992	3	-10.446	0.91909	0.96981	1	-0.69299	0.25071	0.85438
"112"	"Glyoxylate and dicarboxylate metabolism"	23	0.29253	0.26023	1	-0.29253	0.73977	0.89285	-6.995	0.011179	0.2131	14	-3.1019	0.0064128	0.12783	9	-7.3136	0.28277	0.86764
"113"	"GnRH signaling pathway"	33	-0.6297	0.96206	1	0.6297	0.037938	0.1995	-14.979	0.23693	0.68172	13	-11.417	0.50173	0.81336	20	-10.037	0.16889	0.85438
"114"	"Graft-versus-host disease"	4	-0.17092	0.68037	1	0.17092	0.31963	0.63295	-9.3163	0.82222	0.99992	1	-8.2095	0.9244	0.96981	3	-6.0177	0.59718	0.99997
"115"	"HIF-1 signaling pathway"	51	-0.17558	0.71897	1	0.17558	0.28103	0.60176	-20.412	0.32131	0.74121	21	-8.1347	0.041683	0.49187	30	-19.808	0.83327	0.99997
"116"	"Hedgehog signaling pathway"	9	0.008761	0.51319	1	-0.008761	0.48681	0.7392	-12.665	0.84553	0.99992	4	-5.7673	0.45202	0.7968	5	-11.834	0.92952	0.99997
"117"	"Hematopoietic cell lineage"	14	0.15984	0.36267	1	-0.15984	0.63733	0.84149	-13.063	0.68459	0.99992	8	-7.7182	0.3737	0.76011	6	-11.042	0.85669	0.99997
"118"	"Hepatitis B"	53	-0.54778	0.93987	1	0.54778	0.06013	0.24149	-27.54	0.92943	0.99992	20	-17.127	0.82111	0.9553	33	-21.568	0.89003	0.99997
"119"	"Hepatitis C"	50	-0.36684	0.86295	1	0.36684	0.13705	0.41779	-27.114	0.93903	0.99992	19	-15.781	0.72801	0.92332	31	-22.081	0.93628	0.99997
"120"	"Hepatocellular carcinoma"	43	-0.14362	0.68259	1	0.14362	0.31741	0.63295	-22.45	0.74811	0.99992	18	-10.811	0.26939	0.68162	25	-20.269	0.92625	0.99997
"121"	"Herpes simplex virus 1 infection"	59	-0.089518	0.64587	1	0.089518	0.35413	0.64809	-31.651	0.99159	0.99992	30	-20.63	0.87264	0.96981	29	-24.162	0.99048	0.99997
"122"	"Hippo signaling pathway"	34	0.24916	0.28664	1	-0.24916	0.71336	0.88806	-21.585	0.85829	0.99992	21	-13.927	0.46432	0.79788	13	-17.207	0.96684	0.99997
"123"	"Histidine metabolism"	10	-0.10729	0.62929	1	0.10729	0.37071	0.65356	-1.4993	0.0087117	0.17714	4	-0.65711	0.057788	0.54279	6	-1.3991	0.039036	0.64522
"124"	"Homologous recombination"	8	0.17134	0.33962	1	-0.17134	0.66038	0.85009	-8.4573	0.48692	0.9111	6	-6.075	0.32151	0.71209	2	-6.3924	0.72408	0.99997
"125"	"Human T-cell leukemia virus 1 infection"	61	-1.2291	0.99951	1	1.2291	0.00048518	0.0087047	-26.648	0.77536	0.99992	25	-18.446	0.78722	0.95254	36	-19.316	0.63589	0.99997
"126"	"Human cytomegalovirus infection"	77	-0.39499	0.88593	1	0.39499	0.11407	0.38203	-33.009	0.96263	0.99992	30	-20.983	0.89373	0.96981	47	-25.486	0.92905	0.99997
"127"	"Human immunodeficiency virus 1 infection"	80	-0.61303	0.95925	1	0.61303	0.040747	0.2099	-30.615	0.81215	0.99992	31	-18.247	0.58391	0.86005	49	-24.605	0.84122	0.99997
"128"	"Human papillomavirus infection"	110	-1.7849	1	1	1.7849	5.1603e-07	5.2463e-05	-39.947	0.98729	0.99992	34	-29.399	0.99959	0.99959	76	-28.395	0.73206	0.99997
"129"	"Huntington disease"	113	3.8478	0	0	-3.8478	1	1	-16.483	1.1292e-06	8.6101e-05	98	-11.132	1.066e-08	7.9681e-07	15	-16.787	0.93443	0.99997
"130"	"Hypertrophic cardiomyopathy (HCM)"	48	-1.3417	0.9999	1	1.3417	0.00010256	0.0034758	-14.812	0.028642	0.3218	24	-11.325	0.14026	0.60456	24	-9.6228	0.063596	0.67806
"131"	"IL-17 signaling pathway"	25	-0.70148	0.96732	1	0.70148	0.032677	0.19166	-20.949	0.94561	0.99992	10	-14.326	0.89601	0.96981	15	-15.348	0.86224	0.99997
"132"	"Inflammatory bowel disease (IBD)"	8	0.027815	0.48395	1	-0.027815	0.51605	0.74959	-11.014	0.76864	0.99992	3	-5.9053	0.53758	0.82429	5	-9.358	0.77409	0.99997
"133"	"Inflammatory mediator regulation of TRP channels"	29	-0.023272	0.52953	1	0.023272	0.47047	0.7321	-16.004	0.43855	0.85742	15	-11.493	0.44573	0.7968	14	-11.137	0.49719	0.99997
"134"	"Influenza A"	56	-0.29605	0.78738	1	0.29605	0.21262	0.50271	-23.257	0.52287	0.94183	23	-10.68	0.11491	0.60456	33	-21.38	0.87931	0.99997
"135"	"Inositol phosphate metabolism"	24	-0.37646	0.8412	1	0.37646	0.1588	0.45266	-18.057	0.78152	0.99992	11	-12.763	0.75411	0.93365	13	-12.794	0.70651	0.99997
"136"	"Insulin resistance"	53	0.22147	0.31684	1	-0.22147	0.68316	0.86431	-25.56	0.8136	0.99992	27	-15.734	0.44183	0.7968	26	-20.459	0.93652	0.99997
"137"	"Insulin secretion"	22	0.30286	0.25299	1	-0.30286	0.74701	0.89285	-13.035	0.33361	0.74271	14	-9.0246	0.21632	0.65611	8	-9.6773	0.65253	0.99997
"138"	"Insulin signaling pathway"	77	-0.080005	0.64101	1	0.080005	0.35899	0.64974	-29.873	0.80777	0.99992	34	-17.278	0.40534	0.78392	43	-24.612	0.9204	0.99997
"139"	"Intestinal immune network for IgA production"	2	-0.14222	0.66687	1	0.14222	0.33313	0.63503	-6.5099	0.70831	0.99992	0				2	-6.5099	0.73534	0.99997
"140"	"JAK-STAT signaling pathway"	18	-0.12412	0.66078	1	0.12412	0.33922	0.64262	-18.386	0.92921	0.99992	6	-8.8079	0.62179	0.88043	12	-16.29	0.95642	0.99997
"141"	"Kaposi sarcoma-associated herpesvirus infection"	59	-0.64993	0.96538	1	0.64993	0.034618	0.19268	-28.221	0.91403	0.99992	22	-19.433	0.91984	0.96981	37	-20.652	0.76886	0.99997
"142"	"Legionellosis"	23	0.27992	0.27101	1	-0.27992	0.72899	0.89285	-10.889	0.12316	0.54575	13	-6.2983	0.073862	0.5645	10	-9.3328	0.46782	0.99997
"143"	"Leishmaniasis"	15	-0.7465	0.98025	1	0.7465	0.019747	0.12624	-14.764	0.80034	0.99992	4	-12.715	0.96821	0.99126	11	-9.5735	0.44351	0.99997
"144"	"Leukocyte transendothelial migration"	50	0.56326	0.086879	1	-0.56326	0.91312	0.97039	-21.83	0.50026	0.92473	25	-11.244	0.089307	0.60456	25	-19.628	0.89742	0.99997
"145"	"Linoleic acid metabolism"	3	0.13563	0.35712	1	-0.13563	0.64288	0.84397	-9.9955	0.9139	0.99992	3	-9.9955	0.89789	0.96981	0			
"146"	"Long-term depression"	24	-0.31741	0.80138	1	0.31741	0.19862	0.48563	-11.44	0.13764	0.54575	10	-7.3006	0.22602	0.65611	14	-8.8086	0.24821	0.85438
"147"	"Long-term potentiation"	29	-0.81034	0.98472	1	0.81034	0.015282	0.10358	-10.763	0.04454	0.36122	13	-9.5807	0.30275	0.7014	16	-5.8543	0.036344	0.64522
"148"	"Longevity regulating pathway"	44	0.036948	0.49528	1	-0.036948	0.50472	0.74714	-25.135	0.90905	0.99992	22	-14.255	0.46233	0.79788	22	-21.291	0.98022	0.99997
"149"	"Lysine degradation"	22	0.30646	0.25001	1	-0.30646	0.74999	0.89285	-10.552	0.1267	0.54575	13	-5.3402	0.042771	0.49187	9	-10.079	0.58892	0.99997
"150"	"Lysosome"	41	-0.040109	0.57214	1	0.040109	0.42786	0.69785	-25.396	0.95284	0.99992	23	-18.571	0.84636	0.96064	18	-17.337	0.90147	0.99997
"151"	"MAPK signaling pathway"	80	-1.1004	0.99881	1	1.1004	0.0011935	0.019159	-28.807	0.64191	0.99992	29	-20.909	0.88264	0.96981	51	-20.312	0.32047	0.89254
"152"	"Malaria"	13	0.46874	0.10682	1	-0.46874	0.89318	0.95486	-11.28	0.50877	0.92867	9	-5.2123	0.11438	0.60456	4	-12.517	0.96529	0.99997
"153"	"Mannose type O-glycan biosynthesis"	1	0	0.49655	1	0	0.50345	0.74714	-8.2095	0.92789	0.99992	0				1	-8.2095	0.93611	0.99997
"154"	"Maturity onset diabetes of the young"	1	0	0.49655	1	0	0.50345	0.74714	-8.2095	0.92789	0.99992	1	-8.2095	0.9244	0.96981	0			
"155"	"Measles"	40	-0.092098	0.65264	1	0.092098	0.34736	0.64809	-25.735	0.96929	0.99992	18	-14.708	0.68569	0.91121	22	-21.398	0.98163	0.99997
"156"	"Melanogenesis"	23	-0.086673	0.63495	1	0.086673	0.36505	0.64974	-13.339	0.32575	0.74121	11	-9.5777	0.39924	0.78022	12	-9.2965	0.36075	0.95985
"157"	"Melanoma"	14	-0.46877	0.90503	1	0.46877	0.094968	0.32915	-15.506	0.88618	0.99992	5	-9.4723	0.73804	0.92332	9	-12.279	0.80527	0.99997
"158"	"Metabolism of xenobiotics by cytochrome P450"	19	-0.1637	0.66745	1	0.1637	0.33255	0.63503	-7.8862	0.045263	0.36122	7	-1.6885	0.025377	0.36132	12	-8.6336	0.29035	0.86764
"159"	"MicroRNAs in cancer"	43	0.13522	0.39936	1	-0.13522	0.60064	0.8262	-28.566	0.99294	0.99992	17	-17.439	0.90571	0.96981	26	-22.635	0.98546	0.99997
"160"	"Mineral absorption"	12	0.36777	0.18017	1	-0.36777	0.81983	0.91274	-7.6444	0.20109	0.63888	9	-5.6778	0.14236	0.60456	3	-5.4546	0.53146	0.99997
"161"	"Mismatch repair"	7	0.13753	0.35527	1	-0.13753	0.64473	0.84397	-10.886	0.7743	0.99992	4	-5.7762	0.45303	0.7968	3	-9.9591	0.92159	0.99997
"162"	"Mitophagy"	33	0.19066	0.33944	1	-0.19066	0.66056	0.85009	-20.403	0.79082	0.99992	18	-12.454	0.43977	0.7968	15	-16.62	0.928	0.99997
"163"	"Morphine addiction"	14	0.035995	0.49048	1	-0.035995	0.50952	0.74714	-10.651	0.40669	0.82088	6	-7.4359	0.46883	0.80094	8	-7.6505	0.4142	0.97855
"164"	"Mucin type O-glycan biosynthesis"	1	0.80995	0.012434	0.29172	-0.80995	0.98757	1	0.20709	0.17155	0.59369	1	0.20709	0.16742	0.60456	0			
"165"	"N-Glycan biosynthesis"	13	0.18996	0.31422	1	-0.18996	0.68578	0.86431	-13.452	0.74078	0.99992	8	-10.196	0.6492	0.89042	5	-8.7933	0.72179	0.99997
"166"	"NF-kappa B signaling pathway"	20	-0.097334	0.63359	1	0.097334	0.36641	0.64974	-22.545	0.99177	0.99992	7	-11.162	0.78558	0.95254	13	-19.773	0.99518	0.99997
"167"	"NOD-like receptor signaling pathway"	50	0.44362	0.14811	1	-0.44362	0.85189	0.93463	-23.444	0.68187	0.99992	28	-13.404	0.17793	0.60456	22	-20.222	0.96034	0.99997
"168"	"Natural killer cell mediated cytotoxicity"	27	-0.71728	0.96756	1	0.71728	0.032436	0.19166	-15.548	0.45089	0.87592	9	-10.378	0.61059	0.88043	18	-11.705	0.37231	0.97323
"169"	"Necroptosis"	58	0.036195	0.50155	1	-0.036195	0.49845	0.74714	-22.569	0.38503	0.79887	27	-13.042	0.17443	0.60456	31	-18.699	0.7099	0.99997
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	2	0.26975	0.24767	1	-0.26975	0.75233	0.89285	-2.5993	0.28804	0.7321	1	-0.53037	0.22538	0.65611	1	-3.1456	0.51756	0.99997
"171"	"Neuroactive ligand-receptor interaction"	9	-0.10048	0.62677	1	0.10048	0.37323	0.65421	-9.9177	0.57453	0.97351	2	-7.3648	0.80209	0.95254	7	-7.309	0.41312	0.97855
"172"	"Neurotrophin signaling pathway"	48	-0.87261	0.99296	1	0.87261	0.0070406	0.065882	-24.135	0.81799	0.99992	15	-13.477	0.67411	0.89982	33	-20.022	0.78041	0.99997
"173"	"Nicotinate and nicotinamide metabolism"	18	0.17986	0.36386	1	-0.17986	0.63614	0.84149	-18.613	0.93768	0.99992	8	-10.735	0.70426	0.91376	10	-15.37	0.95614	0.99997
"174"	"Nitrogen metabolism"	7	-0.16682	0.67807	1	0.16682	0.32193	0.63295	-2.178	0.041599	0.35244	2	-0.65767	0.13354	0.60456	5	-2.161	0.090061	0.72829
"175"	"Non-alcoholic fatty liver disease (NAFLD)"	96	3.2274	0	0	-3.2274	1	1	-16.516	3.3492e-05	0.0012769	78	-8.6	2.7554e-08	1.6477e-06	18	-20.24	0.98311	0.99997
"176"	"Non-homologous end-joining"	5	-0.34854	0.82118	1	0.34854	0.17882	0.48232	-4.7896	0.28312	0.72565	2	-6.2154	0.69617	0.91376	3	-1.1085	0.11295	0.7518
"177"	"Non-small cell lung cancer"	23	-0.46039	0.9063	1	0.46039	0.093698	0.32915	-16.871	0.71524	0.99992	6	-8.5623	0.59509	0.87221	17	-14.537	0.73181	0.99997
"178"	"Notch signaling pathway"	6	-0.33078	0.81146	1	0.33078	0.18854	0.48563	-16.673	0.99718	0.99992	4	-16.419	0.99818	0.99959	2	-5.6583	0.64901	0.99997
"179"	"Nucleotide excision repair"	11	-0.046042	0.58222	1	0.046042	0.41778	0.68508	-11.377	0.64197	0.99992	6	-8.152	0.54954	0.82986	5	-7.9452	0.63366	0.99997
"180"	"Olfactory transduction"	11	-0.26964	0.77343	1	0.26964	0.22657	0.5235	-11.898	0.69672	0.99992	5	-9.0191	0.69574	0.91376	6	-7.8769	0.55471	0.99997
"181"	"One carbon pool by folate"	11	0.48091	0.14203	1	-0.48091	0.85797	0.93793	-9.7624	0.45812	0.88262	8	-9.8791	0.61523	0.88043	3	-2.5611	0.21774	0.85438
"182"	"Oocyte meiosis"	41	-0.6393	0.95815	1	0.6393	0.04185	0.2099	-14.257	0.053285	0.36122	18	-10.625	0.25233	0.68016	23	-9.6357	0.080513	0.72705
"183"	"Osteoclast differentiation"	32	-1.0634	0.99722	1	1.0634	0.0027755	0.035662	-22.631	0.9333	0.99992	11	-16.826	0.97063	0.99126	21	-15.759	0.7131	0.99997
"184"	"Other glycan degradation"	6	-0.010687	0.52056	1	0.010687	0.47944	0.7392	-7.8476	0.56449	0.96568	3	-5.6226	0.50522	0.81336	3	-5.4756	0.53394	0.99997
"185"	"Other types of O-glycan biosynthesis"	4	0.4085	0.16153	1	-0.4085	0.83847	0.9285	-5.5063	0.42941	0.84553	2	-0.85073	0.14607	0.60456	2	-6.9363	0.77409	0.99997
"186"	"Ovarian steroidogenesis"	9	-0.32855	0.82361	1	0.32855	0.17639	0.48035	-12.236	0.81271	0.99992	3	-9.9955	0.89789	0.96981	6	-7.9182	0.55949	0.99997
"187"	"Oxidative phosphorylation"	93	3.5344	0	0	-3.5344	1	1	-6.4912	6.1572e-12	1.8779e-09	81	-5.5899	4.971e-11	7.4316e-09	12	-3.5479	0.019919	0.64522
"188"	"Oxytocin signaling pathway"	63	-0.64758	0.96526	1	0.64758	0.034745	0.19268	-18.409	0.041361	0.35244	27	-12.492	0.13603	0.60456	36	-13.534	0.085005	0.72829
"189"	"PI3K-Akt signaling pathway"	101	-1.3479	0.99985	1	1.3479	0.00014701	0.0044837	-35.081	0.89391	0.99992	33	-21.738	0.86913	0.96981	68	-27.611	0.7745	0.99997
"190"	"PPAR signaling pathway"	35	-0.48932	0.91182	1	0.48932	0.088181	0.32018	-12.97	0.059238	0.36122	18	-12.152	0.40638	0.78392	17	-6.1061	0.029925	0.64522
"191"	"Pancreatic cancer"	31	-0.39819	0.86213	1	0.39819	0.13787	0.41779	-22.138	0.92412	0.99992	11	-9.9235	0.43922	0.7968	20	-20.202	0.9682	0.99997
"192"	"Pancreatic secretion"	23	0.49843	0.11922	1	-0.49843	0.88078	0.954	-12.655	0.2581	0.69664	14	-8.4911	0.17408	0.60456	9	-9.6398	0.53895	0.99997
"193"	"Pantothenate and CoA biosynthesis"	8	-0.36008	0.8336	1	0.36008	0.1664	0.4656	-9.7663	0.64054	0.99992	2	-5.9485	0.66838	0.89617	6	-7.8427	0.55075	0.99997
"194"	"Parathyroid hormone synthesis, secretion and action"	23	-0.070004	0.61852	1	0.070004	0.38148	0.65473	-16.093	0.6346	0.99992	11	-9.5435	0.39534	0.78022	12	-13.143	0.78239	0.99997
"195"	"Parkinson disease"	98	4.1139	0	0	-4.1139	1	1	-8.4124	2.28e-11	3.477e-09	89	-5.8273	1.9408e-12	5.8029e-10	9	-9.4347	0.51535	0.99997
"196"	"Pathogenic Escherichia coli infection"	33	0.34985	0.20079	1	-0.34985	0.79921	0.90617	-14.635	0.20811	0.64116	14	-6.2914	0.058092	0.54279	19	-13.887	0.56098	0.99997
"197"	"Pathways in cancer"	140	-1.0069	0.99726	1	1.0069	0.0027371	0.035662	-39.239	0.79481	0.99992	54	-24.224	0.66773	0.89617	86	-30.87	0.79555	0.99997
"198"	"Pentose and glucuronate interconversions"	7	0.11263	0.38097	1	-0.11263	0.61903	0.83737	-2.7347	0.057801	0.36122	3	-1.389	0.11441	0.60456	4	-2.4148	0.13786	0.80553
"199"	"Pentose phosphate pathway"	22	-0.80704	0.98681	1	0.80704	0.01319	0.097897	-12.117	0.24414	0.68172	7	-9.0068	0.56624	0.84674	15	-8.5222	0.18446	0.85438
"200"	"Peroxisome"	42	0.63175	0.07005	1	-0.63175	0.92995	0.98484	-20.397	0.52804	0.94183	29	-19.143	0.75187	0.93365	13	-8.0705	0.20019	0.85438
"201"	"Pertussis"	28	-0.69448	0.96277	1	0.69448	0.037232	0.19922	-15.286	0.37934	0.79245	8	-8.5004	0.46039	0.79788	20	-12.711	0.41354	0.97855
"202"	"Phagosome"	59	-0.45806	0.90707	1	0.45806	0.092926	0.32915	-18.35	0.056633	0.36122	29	-14.696	0.27484	0.68162	30	-11.284	0.052127	0.65639
"203"	"Phenylalanine metabolism"	6	-0.10803	0.61963	1	0.10803	0.38037	0.65473	-5.1708	0.26497	0.7089	2	-1.2782	0.17655	0.60456	4	-5.4291	0.41179	0.97855
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	2	0.34511	0.18795	1	-0.34511	0.81205	0.91274	-1.2782	0.17534	0.59369	2	-1.2782	0.17655	0.60456	0			
"205"	"Phosphatidylinositol signaling system"	28	-0.31714	0.79938	1	0.31714	0.20062	0.48563	-20.176	0.87449	0.99992	13	-14.396	0.80216	0.95254	15	-14.164	0.77196	0.99997
"206"	"Phospholipase D signaling pathway"	40	-0.15357	0.70956	1	0.15357	0.29044	0.61069	-19.133	0.48212	0.90769	20	-11.892	0.26737	0.68162	20	-15.167	0.67772	0.99997
"207"	"Phosphonate and phosphinate metabolism"	2	-0.4264	0.88477	1	0.4264	0.11523	0.38203	0.063503	0.094543	0.44363	1	-0.43089	0.21696	0.65611	1	0.5207	0.15228	0.84743
"208"	"Phototransduction"	2	-0.23901	0.75578	1	0.23901	0.24422	0.54498	-6.2499	0.68253	0.99992	1	-8.2095	0.9244	0.96981	1	-0.6291	0.24481	0.85438
"209"	"Platelet activation"	53	-0.92776	0.99471	1	0.92776	0.0052864	0.054571	-20.966	0.3246	0.74121	25	-14.314	0.33285	0.72117	28	-15.32	0.37163	0.97323
"210"	"Porphyrin and chlorophyll metabolism"	18	1.0454	0.0058677	0.14914	-1.0454	0.99413	1	-6.8765	0.03113	0.3218	13	-2.4366	0.0054946	0.12783	5	-9.1185	0.75261	0.99997
"211"	"Primary bile acid biosynthesis"	6	0.40828	0.14985	1	-0.40828	0.85015	0.93463	-4.9218	0.24145	0.68172	4	-4.7928	0.34544	0.73254	2	-1.7468	0.22693	0.85438
"212"	"Primary immunodeficiency"	3	-0.16229	0.64604	1	0.16229	0.35396	0.64809	-9.9227	0.91056	0.99992	0				3	-9.9227	0.92	0.99997
"213"	"Prion diseases"	21	-1.2949	0.99966	1	1.2949	0.00034231	0.0069066	-16.316	0.74704	0.99992	5	-9.3298	0.72507	0.92332	16	-13.476	0.66701	0.99997
"214"	"Progesterone-mediated oocyte maturation"	25	-1.1886	0.99887	1	1.1886	0.0011345	0.019159	-16.764	0.66039	0.99992	6	-8.8308	0.62425	0.88043	19	-14.267	0.60322	0.99997
"215"	"Prolactin signaling pathway"	24	-0.89694	0.99052	1	0.89694	0.0094784	0.079203	-16.468	0.62881	0.99992	6	-8.9744	0.63957	0.88763	18	-13.834	0.61225	0.99997
"216"	"Propanoate metabolism"	29	0.9692	0.0052402	0.1453	-0.9692	0.99476	1	-9.398	0.01774	0.24594	22	-4.9158	0.0025789	0.077109	7	-10.414	0.75446	0.99997
"217"	"Prostate cancer"	30	-0.41612	0.88215	1	0.41612	0.11785	0.38651	-21.999	0.94238	0.99992	10	-9.9766	0.50559	0.81336	20	-19.889	0.96148	0.99997
"218"	"Proteasome"	39	-1.03	0.99696	1	1.03	0.00304	0.035662	-8.0495	0.00079793	0.024965	13	-8.5254	0.20729	0.65611	26	-3.8302	0.00024382	0.072658
"219"	"Protein digestion and absorption"	26	-0.88226	0.98879	1	0.88226	0.011215	0.090012	-12.503	0.19775	0.63488	5	-4.8886	0.26494	0.68162	21	-11.527	0.25831	0.85438
"220"	"Protein export"	14	0.73455	0.030678	0.58479	-0.73455	0.96932	1	-8.2106	0.1682	0.59369	11	-7.3122	0.17727	0.60456	3	-3.7351	0.33309	0.919
"221"	"Protein processing in endoplasmic reticulum"	97	0.15608	0.40507	1	-0.15608	0.59493	0.82478	-26.495	0.11981	0.54541	55	-17.891	0.06427	0.54871	42	-19.79	0.52388	0.99997
"222"	"Proteoglycans in cancer"	83	-0.086253	0.647	1	0.086253	0.353	0.64809	-24.255	0.13486	0.54575	34	-15.472	0.21953	0.65611	49	-18.679	0.22097	0.85438
"223"	"Proximal tubule bicarbonate reclamation"	10	0.13795	0.37952	1	-0.13795	0.62048	0.83737	-4.8686	0.078767	0.40719	6	-4.8583	0.20957	0.65611	4	-1.7477	0.099945	0.74459
"224"	"Purine metabolism"	56	0.15173	0.36681	1	-0.15173	0.63319	0.84149	-20.043	0.19641	0.63488	27	-13.248	0.19038	0.61882	29	-15.069	0.35563	0.95476
"225"	"Pyrimidine metabolism"	28	-0.20014	0.70767	1	0.20014	0.29233	0.61069	-20.91	0.91409	0.99992	10	-9.8212	0.48784	0.81336	18	-18.759	0.95526	0.99997
"226"	"Pyruvate metabolism"	34	0.30934	0.23705	1	-0.30934	0.76295	0.89674	-10.624	0.017082	0.24594	20	-6.8072	0.01714	0.27222	14	-8.4196	0.21402	0.85438
"227"	"RIG-I-like receptor signaling pathway"	21	-0.3747	0.84804	1	0.3747	0.15196	0.44061	-21.185	0.98248	0.99992	7	-10.625	0.73754	0.92332	14	-18.433	0.98221	0.99997
"228"	"RNA degradation"	36	-0.28497	0.80164	1	0.28497	0.19836	0.48563	-23.041	0.90456	0.99992	13	-12.379	0.60919	0.88043	23	-19.519	0.93047	0.99997
"229"	"RNA polymerase"	9	0.26998	0.25434	1	-0.26998	0.74566	0.89285	-21.823	0.99992	0.99992	4	-12.211	0.95652	0.99126	5	-18.357	0.99962	0.99997
"230"	"RNA transport"	92	-0.94192	0.99664	1	0.94192	0.0033602	0.037958	-25.312	0.10886	0.50306	35	-19.723	0.6345	0.88763	57	-16.702	0.039381	0.64522
"231"	"Rap1 signaling pathway"	52	-0.21476	0.75685	1	0.21476	0.24315	0.54498	-19.636	0.20778	0.64116	26	-14.062	0.31434	0.7014	26	-13.707	0.30517	0.87442
"232"	"Ras signaling pathway"	59	-0.2786	0.80536	1	0.2786	0.19464	0.48563	-29.493	0.95961	0.99992	26	-18.982	0.81127	0.95254	33	-22.588	0.93646	0.99997
"233"	"Regulation of actin cytoskeleton"	97	0.0099512	0.55764	1	-0.0099512	0.44236	0.71197	-25.684	0.077545	0.40719	42	-15.683	0.087407	0.60456	55	-20.404	0.26764	0.85438
"234"	"Regulation of lipolysis in adipocytes"	16	0.032305	0.49674	1	-0.032305	0.50326	0.74714	-17.115	0.90839	0.99992	7	-6.3766	0.27584	0.68162	9	-17.197	0.98876	0.99997
"235"	"Relaxin signaling pathway"	41	-0.95736	0.99463	1	0.95736	0.0053677	0.054571	-19.824	0.51153	0.92867	13	-11.712	0.53504	0.82429	28	-16.009	0.45271	0.99997
"236"	"Renal cell carcinoma"	30	-0.46389	0.90544	1	0.46389	0.094558	0.32915	-13.447	0.17076	0.59369	12	-8.184	0.22018	0.65611	18	-10.678	0.26756	0.85438
"237"	"Renin secretion"	19	-0.83889	0.9853	1	0.83889	0.014697	0.10187	-10.017	0.14488	0.55236	6	-5.8387	0.29793	0.69594	13	-8.1437	0.20625	0.85438
"238"	"Renin-angiotensin system"	11	-0.15434	0.68096	1	0.15434	0.31904	0.63295	-5.3436	0.082525	0.4118	3	-1.1859	0.10351	0.60456	8	-5.5397	0.19741	0.85438
"239"	"Retinol metabolism"	9	-0.39023	0.86282	1	0.39023	0.13718	0.41779	-6.975	0.24178	0.68172	3	-5.1075	0.44633	0.7968	6	-4.9311	0.23384	0.85438
"240"	"Retrograde endocannabinoid signaling"	61	2.0999	6.3805e-08	2.7801e-06	-2.0999	1	1	-9.5987	9.4115e-06	0.00047842	46	-6.5788	9.8408e-06	0.00042034	15	-7.836	0.13601	0.80553
"241"	"Rheumatoid arthritis"	16	-1.0742	0.99711	1	1.0742	0.0028944	0.035662	-11.496	0.4019	0.81719	5	-11.866	0.90288	0.96981	11	-5.8652	0.11171	0.7518
"242"	"Riboflavin metabolism"	5	-0.089064	0.59702	1	0.089064	0.40298	0.67164	-5.1912	0.32409	0.74121	2	-1.3991	0.18586	0.61745	3	-5.5594	0.54381	0.99997
"243"	"Ribosome"	111	-0.18837	0.7484	1	0.18837	0.2516	0.55608	-18.404	2.3022e-05	0.0010031	48	-13.423	0.006312	0.12783	63	-12.712	0.00053026	0.079009
"244"	"Ribosome biogenesis in eukaryotes"	22	0.13791	0.40662	1	-0.13791	0.59338	0.82478	-17.526	0.80461	0.99992	15	-14.767	0.79776	0.95254	7	-9.4539	0.65828	0.99997
"245"	"SNARE interactions in vesicular transport"	18	0.39967	0.18414	1	-0.39967	0.81586	0.91274	-18.091	0.91689	0.99992	10	-9.9438	0.50184	0.81336	8	-16.019	0.9892	0.99997
"246"	"Salivary secretion"	22	0.34885	0.21632	1	-0.34885	0.78368	0.8977	-12.449	0.27493	0.72397	13	-8.5222	0.20703	0.65611	9	-9.2212	0.49074	0.99997
"247"	"Salmonella infection"	45	-0.39877	0.86055	1	0.39877	0.13945	0.41779	-15.761	0.081512	0.4118	18	-10.439	0.23592	0.6691	27	-11.824	0.12278	0.77851
"248"	"Selenocompound metabolism"	9	0.038737	0.48143	1	-0.038737	0.51857	0.74959	-1.9401	0.013182	0.21446	5	-1.6152	0.062768	0.54871	4	-1.1043	0.071196	0.72705
"249"	"Serotonergic synapse"	26	-0.60186	0.94215	1	0.60186	0.057848	0.24149	-14.122	0.34925	0.75345	11	-13.916	0.84819	0.96064	15	-6.6752	0.075408	0.72705
"250"	"Shigellosis"	39	-0.31666	0.80988	1	0.31666	0.19012	0.48563	-17.524	0.32797	0.74121	12	-5.9556	0.076901	0.5645	27	-17.091	0.64619	0.99997
"251"	"Signaling pathways regulating pluripotency of stem cells"	19	-0.42089	0.86383	1	0.42089	0.13617	0.41779	-14.141	0.56675	0.96568	7	-8.4515	0.50237	0.81336	12	-11.339	0.59759	0.99997
"252"	"Small cell lung cancer"	34	-1.3571	0.99978	1	1.3571	0.00022375	0.0048745	-25.008	0.98073	0.99992	9	-12.663	0.82575	0.95698	25	-21.566	0.9653	0.99997
"253"	"Sphingolipid metabolism"	7	-0.35825	0.83807	1	0.35825	0.16193	0.45731	-15.779	0.98421	0.99992	2	-11.61	0.98165	0.9916	5	-11.327	0.90741	0.99997
"254"	"Sphingolipid signaling pathway"	45	-0.5927	0.94171	1	0.5927	0.058294	0.24149	-22.234	0.68628	0.99992	16	-13.111	0.54924	0.82986	29	-17.959	0.68882	0.99997
"255"	"Spliceosome"	94	0.27957	0.31109	1	-0.27957	0.68891	0.86468	-37.974	0.98875	0.99992	47	-25.196	0.87025	0.96981	47	-28.507	0.99124	0.99997
"256"	"Staphylococcus aureus infection"	15	-0.085722	0.61704	1	0.085722	0.38296	0.65473	-13.063	0.63499	0.99992	4	-6.3638	0.51957	0.81336	11	-11.417	0.6527	0.99997
"257"	"Starch and sucrose metabolism"	19	-0.40102	0.8523	1	0.40102	0.1477	0.43317	-9.9541	0.14064	0.54575	5	-2.3791	0.093242	0.60456	14	-10.174	0.38768	0.97855
"258"	"Steroid biosynthesis"	6	0.47418	0.11346	1	-0.47418	0.88654	0.954	-10.916	0.85737	0.99992	5	-8.2868	0.62173	0.88043	1	-8.2095	0.93611	0.99997
"259"	"Steroid hormone biosynthesis"	6	-0.29332	0.78405	1	0.29332	0.21595	0.50664	-4.8127	0.23152	0.68172	3	-5.6871	0.51262	0.81336	3	-1.1191	0.11356	0.7518
"260"	"Sulfur metabolism"	6	0.17504	0.33322	1	-0.17504	0.66678	0.85091	-1.7837	0.051724	0.36122	3	-1.0933	0.098803	0.60456	3	-1.4293	0.13226	0.80435
"261"	"Sulfur relay system"	6	-0.075907	0.58746	1	0.075907	0.41254	0.68316	-5.6109	0.30919	0.74121	3	-2.2839	0.17201	0.60456	3	-5.6511	0.55459	0.99997
"262"	"Synaptic vesicle cycle"	24	-0.78164	0.97972	1	0.78164	0.020281	0.12624	-10.602	0.092146	0.44363	13	-13.272	0.70212	0.91376	11	-1.2323	0.005219	0.51842
"263"	"Synthesis and degradation of ketone bodies"	8	0.31304	0.2171	1	-0.31304	0.7829	0.8977	-7.3116	0.35326	0.75345	5	-1.8582	0.071479	0.5645	3	-9.5408	0.90177	0.99997
"264"	"Systemic lupus erythematosus"	22	-0.50788	0.92546	1	0.50788	0.074542	0.27726	-14.961	0.54872	0.95848	5	-6.4475	0.4216	0.7968	17	-13.523	0.62457	0.99997
"265"	"T cell receptor signaling pathway"	36	-1.1069	0.99865	1	1.1069	0.001347	0.020542	-19.595	0.62272	0.99992	13	-14.315	0.79568	0.95254	23	-13.754	0.42021	0.97855
"266"	"TGF-beta signaling pathway"	15	-0.40265	0.87337	1	0.40265	0.12663	0.40231	-12.176	0.53398	0.94689	6	-5.1854	0.23721	0.6691	9	-11.485	0.73601	0.99997
"267"	"TNF signaling pathway"	26	-0.58288	0.93638	1	0.58288	0.063624	0.24564	-21.966	0.96806	0.99992	9	-12.857	0.83968	0.9597	17	-17.81	0.94398	0.99997
"268"	"Taste transduction"	2	-0.2665	0.77849	1	0.2665	0.22151	0.51574	-6.1886	0.67633	0.99992	0				2	-6.1886	0.70404	0.99997
"269"	"Taurine and hypotaurine metabolism"	2	-0.30909	0.81116	1	0.30909	0.18884	0.48563	-6.1006	0.66732	0.99992	0				2	-6.1006	0.69519	0.99997
"270"	"Terpenoid backbone biosynthesis"	15	-0.14559	0.67626	1	0.14559	0.32374	0.63295	-12.314	0.55004	0.95848	4	-4.6378	0.32935	0.7188	11	-11.583	0.67026	0.99997
"271"	"Th1 and Th2 cell differentiation"	22	-1.4972	0.99997	1	1.4972	2.9739e-05	0.0014955	-13.916	0.42969	0.84553	3	-9.9425	0.89515	0.96981	19	-11.024	0.25406	0.85438
"272"	"Th17 cell differentiation"	28	-1.3933	0.99979	1	1.3933	0.0002057	0.004826	-14.688	0.31372	0.74121	6	-11.098	0.83107	0.95942	22	-10.774	0.17666	0.85438
"273"	"Thermogenesis"	132	3.5294	0	0	-3.5294	1	1	-19.679	2.8597e-06	0.00017444	112	-15.735	1.3619e-07	6.7869e-06	20	-13.319	0.48	0.99997
"274"	"Thiamine metabolism"	7	0.18517	0.30797	1	-0.18517	0.69203	0.86503	-5.9428	0.25531	0.69664	5	-5.8053	0.35379	0.73545	2	-1.9389	0.24402	0.85438
"275"	"Thyroid cancer"	11	-0.33726	0.81972	1	0.33726	0.18028	0.48232	-6.5916	0.15247	0.56711	4	-4.7052	0.33631	0.72339	7	-4.7062	0.16336	0.85404
"276"	"Thyroid hormone signaling pathway"	42	-0.0028648	0.55647	1	0.0028648	0.44353	0.71197	-20.637	0.55481	0.95848	21	-10.919	0.17302	0.60456	21	-18.266	0.89971	0.99997
"277"	"Thyroid hormone synthesis"	21	0.28718	0.24985	1	-0.28718	0.75015	0.89285	-9.1302	0.071634	0.39015	13	-5.5966	0.049816	0.53018	8	-7.6582	0.4151	0.97855
"278"	"Tight junction"	80	0.05864	0.48279	1	-0.05864	0.51721	0.74959	-28.57	0.61606	0.99992	43	-23.019	0.75566	0.93365	37	-17.195	0.38529	0.97855
"279"	"Toll-like receptor signaling pathway"	29	-0.68325	0.96603	1	0.68325	0.033966	0.19268	-20.988	0.9058	0.99992	11	-14.522	0.88651	0.96981	18	-15.288	0.75871	0.99997
"280"	"Toxoplasmosis"	41	-1.4345	0.99992	1	1.4345	7.7236e-05	0.0029446	-17.917	0.29676	0.73587	12	-9.306	0.32926	0.7188	29	-15.318	0.38366	0.97855
"281"	"Transcriptional misregulation in cancer"	23	0.29494	0.2582	1	-0.29494	0.7418	0.89285	-26.634	0.99965	0.99992	14	-18.574	0.97515	0.99126	9	-19.412	0.99826	0.99997
"282"	"Tryptophan metabolism"	21	0.27269	0.26185	1	-0.27269	0.73815	0.89285	-8.8016	0.059252	0.36122	12	-5.1542	0.048291	0.53018	9	-7.4931	0.30058	0.87305
"283"	"Tuberculosis"	54	-0.57344	0.95802	1	0.57344	0.041979	0.2099	-22.904	0.50675	0.92867	25	-16.343	0.56797	0.84674	29	-16.08	0.47276	0.99997
"284"	"Type I diabetes mellitus"	5	-0.025825	0.5324	1	0.025825	0.4676	0.73137	-8.6725	0.7125	0.99992	2	-6.3424	0.70901	0.91376	3	-6.0177	0.59718	0.99997
"285"	"Type II diabetes mellitus"	18	-0.46785	0.89921	1	0.46785	0.10079	0.3454	-15.058	0.69346	0.99992	5	-4.7548	0.25298	0.68016	13	-14.77	0.8691	0.99997
"286"	"Tyrosine metabolism"	13	-0.525	0.92845	1	0.525	0.071546	0.2694	-5.5609	0.052565	0.36122	2	-1.2782	0.17655	0.60456	11	-5.5003	0.092869	0.72829
"287"	"Ubiquinone and other terpenoid-quinone biosynthesis"	6	0.25039	0.26539	1	-0.25039	0.73461	0.89285	-8.4527	0.63347	0.99992	4	-5.5547	0.42818	0.7968	2	-6.785	0.76071	0.99997
"288"	"Ubiquitin mediated proteolysis"	51	-0.8353	0.98759	1	0.8353	0.012409	0.096723	-24.824	0.78143	0.99992	19	-21.83	0.99054	0.99721	32	-14.518	0.20683	0.85438
"289"	"VEGF signaling pathway"	28	-0.80378	0.98017	1	0.80378	0.019829	0.12624	-15.239	0.37397	0.78662	8	-7.9512	0.39907	0.78022	20	-13.002	0.44517	0.99997
"290"	"Valine, leucine and isoleucine degradation"	41	1.3179	0.00044023	0.014638	-1.3179	0.99956	1	-9.4713	0.0012396	0.031506	33	-5.7698	0.00028192	0.010537	8	-9.7231	0.6576	0.99997
"291"	"Vascular smooth muscle contraction"	40	-0.57148	0.94923	1	0.57148	0.050769	0.24149	-13.734	0.053545	0.36122	15	-8.4879	0.15227	0.60456	25	-10.797	0.10869	0.7518
"292"	"Vasopressin-regulated water reabsorption"	22	-0.86645	0.99123	1	0.86645	0.0087738	0.078692	-8.2103	0.03487	0.3218	5	-1.6919	0.065423	0.54871	17	-8.4224	0.11605	0.7518
"293"	"Vibrio cholerae infection"	21	-0.58775	0.94252	1	0.58775	0.057484	0.24149	-8.6698	0.054786	0.36122	8	-6.7317	0.2733	0.68162	13	-5.7384	0.06371	0.67806
"294"	"Viral carcinogenesis"	66	-0.39938	0.8747	1	0.39938	0.1253	0.40229	-26.059	0.61836	0.99992	27	-21.576	0.94174	0.98455	39	-15.947	0.19968	0.85438
"295"	"Viral myocarditis"	25	-2.0605	1	1	2.0605	9.0557e-08	1.381e-05	-8.7375	0.030806	0.3218	7	-7.4788	0.39131	0.78022	18	-5.6334	0.019346	0.64522
"296"	"Vitamin B6 metabolism"	3	0.29086	0.22598	1	-0.29086	0.77402	0.89762	-1.4787	0.13879	0.54575	2	-0.95078	0.15287	0.60456	1	-1.2165	0.30176	0.87305
"297"	"Vitamin digestion and absorption"	5	0.27577	0.24122	1	-0.27577	0.75878	0.89674	-5.3735	0.34346	0.74826	3	-1.6369	0.12878	0.60456	2	-6.4914	0.73358	0.99997
"298"	"Wnt signaling pathway"	37	-0.51356	0.91677	1	0.51356	0.08323	0.30585	-17.835	0.4091	0.82088	19	-14.278	0.56921	0.84674	18	-10.901	0.28898	0.86764
"299"	"alpha-Linolenic acid metabolism"	4	0.30591	0.23263	1	-0.30591	0.76737	0.89674	-8.9276	0.79146	0.99992	3	-5.569	0.49908	0.81336	1	-8.2095	0.93611	0.99997
"300"	"beta-Alanine metabolism"	18	0.52163	0.11396	1	-0.52163	0.88604	0.954	-7.7453	0.053399	0.36122	11	-4.0657	0.029598	0.40227	7	-7.3235	0.41478	0.97855
"301"	"cAMP signaling pathway"	56	-0.26381	0.76283	1	0.26381	0.23717	0.53997	-20.97	0.27709	0.72397	29	-13.438	0.16856	0.60456	27	-16.273	0.55419	0.99997
"302"	"cGMP-PKG signaling pathway"	56	-0.31442	0.80068	1	0.31442	0.19932	0.48563	-15.168	0.012623	0.21446	28	-8.5086	0.010039	0.17657	28	-12.942	0.14715	0.84326
"303"	"mRNA surveillance pathway"	43	-0.044815	0.58563	1	0.044815	0.41437	0.68316	-24.028	0.87062	0.99992	23	-18.404	0.83499	0.9597	20	-15.496	0.70963	0.99997
"304"	"mTOR signaling pathway"	59	-1.0677	0.99809	1	1.0677	0.0019112	0.027758	-24.123	0.55623	0.95848	22	-17.05	0.76253	0.9363	37	-17.314	0.3989	0.97855
"305"	"p53 signaling pathway"	11	0.29199	0.27001	1	-0.29199	0.72999	0.89285	-13.279	0.82014	0.99992	5	-4.4963	0.23071	0.66328	6	-13.875	0.97105	0.99997
